EUVIMEDEUVIMED entdecken
Open Access

Δ9-Tetrahydrocannabinol Alleviates Hyperalgesia in a Humanized Mouse Model of Sickle Cell Disease

Alex Mabou Tagne iD, Yannick Fotio iD, Kalpna Gupta, Daniele Piomelli

The Journal of Pharmacology and Experimental Therapeutics · 2024-11 · 391 (2) · 174-181

DOI: 10.1124/jpet.124.002285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024-11. Verfasst von Alex Mabou Tagne und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Anatomy and Neurobiology (A.M.T., Y.F., D.P.), Biological Chemistry (D.P.), and Pharmaceutical Sciences (D.P.), and Hematology/Oncolog…. Hauptthemen laut MEDLINE: Dronabinol, Anemia, Sickle Cell, Hyperalgesia, Disease Models, Animal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCCIH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

People with sickle cell disease (SCD) often experience chronic pain as well as unpredictable episodes of acute pain, which significantly affects their quality of life and life expectancy. Current treatment strategies for SCD-associated pain primarily rely on opioid analgesics, which have limited efficacy and cause serious adverse effects. Cannabis has emerged as a potential alternative, yet its efficacy remains uncertain. In this study, we investigated the antinociceptive effects of Δ9-tetrahydrocannabinol (THC), cannabis' intoxicating constituent, in male HbSS mice, which express >99% human sickle hemoglobin, and male HbAA mice, which express normal human hemoglobin A, as a control. Acute THC administration (0.1-3 mg/kg-1, i.p.) dose-dependently reduced mechanical and cold hypersensitivity in human sickle hemoglobin (HbSS) but not human normal hemoglobin A (HbAA) mice. In the tail-flick assay, THC (1 and 3 mg/kg-1, i.p.) produced substantial antinociceptive effects in HbSS mice. By contrast, THC (1 mg/kg-1, i.p.) did not alter anxiety-like behavior (elevated plus maze) or long-term memory (24-hour novel object recognition). Subchronic THC treatment (1 and 3 mg/kg-1, i.p.) provided sustained relief of mechanical hypersensitivity but led to tolerance in cold hypersensitivity in HbSS mice. Together, the findings identify THC as a possible therapeutic option for the management of chronic pain in SCD. Further research is warranted to elucidate its mechanism of action and possible interaction with other cannabis constituents. SIGNIFICANCE STATEMENT: The study explores Δ9-tetrahydrocannabinol (THC)'s efficacy in alleviating pain in sickle cell disease (SCD) using a humanized mouse model. Findings indicate that acute THC administration reduces mechanical and cold hypersensitivity in SCD mice without impacting emotional and cognitive dysfunction. Subchronic THC treatment offers sustained relief of mechanical hypersensitivity but leads to cold hypersensitivity tolerance. These results offer insights into THC's potential as an alternative pain management option in SCD, highlighting both its benefits and limitations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DronabinolAnemia, Sickle CellHyperalgesiaDisease Models, AnimalAnimalsMiceMaleHumans

Substanzen

Dronabinol

Autor:innen und Institutionen

  • Departments of Anatomy and Neurobiology (A.M.T., Y.F., D.P.), Biological Chemistry (D.P.), and Pharmaceutical Sciences (D.P.), and Hematology/Oncology, Department of Medicine (K.G.), University of California Irvine, Irv…

ORCID-Profile: Alex Mabou Tagne, Yannick Fotio

Förderung

  • NCCIH NIH HHS

Zitieren

APA

Mabou Tagne, A., Fotio, Y., Gupta, K., & Piomelli, D. (2024). Δ9-Tetrahydrocannabinol Alleviates Hyperalgesia in a Humanized Mouse Model of Sickle Cell Disease. The Journal of Pharmacology and Experimental Therapeutics, 391(2), 174-181. https://doi.org/10.1124/jpet.124.002285

Vancouver

Mabou Tagne A, Fotio Y, Gupta K, Piomelli D. Δ9-Tetrahydrocannabinol Alleviates Hyperalgesia in a Humanized Mouse Model of Sickle Cell Disease. The Journal of Pharmacology and Experimental Therapeutics. 2024;391(2):174-181. doi:10.1124/jpet.124.002285

BibTeX
@article{MabouTagne2024,
  author = {Mabou Tagne, Alex and Fotio, Yannick and Gupta, Kalpna and Piomelli, Daniele},
  title = {Δ9-Tetrahydrocannabinol Alleviates Hyperalgesia in a Humanized Mouse Model of Sickle Cell Disease},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  volume = {391},
  number = {2},
  pages = {174--181},
  doi = {10.1124/jpet.124.002285}
}
Kostenlos starten →